Futuximab
Product Specifications
CAS Number
1310460-85-5
Target
EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.975
Bioactivity
Futuximab is a chimeric monoclonal antibody targeting EGFR, commonly used in combination with zatuximab to form Sym004. Sym004 targets non-overlapping epitopes on EGFR, exhibiting antitumour activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RR212900L4V 200 µL
Ugt1a3 (NM_201424) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
